Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen

PURPOSE: To evaluate the prognosis of estrogen receptor‐positive breast cancer patients with CYP2D6*10 mutant genotypes under tamoxifen or toremifen therapy. METHODS: Estrogen receptor‐positive breast cancer patients were selected and CYP2D6*10 genotypes (C/C, C/T, and T/T) were determined by Sanger...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongyue, Ma, Xinchi, Zhang, Bin, Zhang, Yaotian, Han, Ning, Wei, Linlin, Sun, Chaonan, Sun, Shichen, Zeng, Xue, Guo, Hong, Li, Yubing, Zhang, Yanyu, Zhao, Jiaming, Qin, Zilan, Liu, Zhuang, Zhang, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290498/
https://www.ncbi.nlm.nih.gov/pubmed/34196110
http://dx.doi.org/10.1111/ajco.13571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290498/
https://www.ncbi.nlm.nih.gov/pubmed/34196110
http://dx.doi.org/10.1111/ajco.13571

Ejemplares similares